XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Revenues and Adjusted Segment Earnings before Interest, Taxes, Depreciation and Amortization for Reportable Segments
The table below presents revenues and Adjusted Segment EBITDA for our reportable segments:
 Three Months Ended March 31,
 20242023
Revenues  
Corporate Finance (1)
$366,010 $315,652 
FLC (1)
176,074 157,739 
Economic Consulting204,548 169,595 
Technology100,713 90,618 
Strategic Communications81,208 73,102 
Total revenues$928,553 $806,706 
Adjusted Segment EBITDA  
Corporate Finance (1)
$75,225 $51,847 
FLC (1)
33,709 21,784 
Economic Consulting14,150 14,193 
Technology14,581 15,366 
Strategic Communications12,426 9,556 
Total Adjusted Segment EBITDA$150,091 $112,746 
(1)Effective July 1, 2023, prior period segment information for the Corporate Finance and FLC segments has been recast in this Quarterly Report on Form 10-Q to include the reclassification of a portion of the Company’s health solutions practice in the FLC segment to our realigned business transformation practice within our Corporate Finance segment.
Schedule of Reconciliation of Net Income to Adjusted Segment Earnings Before Interest, Taxes, Depreciation and Amortization
The table below reconciles net income to Total Adjusted Segment EBITDA:
 Three Months Ended March 31,
 20242023
Net income$79,965 $47,547 
Add back:
Income tax provision19,530 14,974 
Interest income and other(1,581)1,342 
Interest expense1,719 2,939 
Unallocated corporate expenses39,531 34,735 
Segment depreciation expense9,911 9,027 
Amortization of intangible assets1,016 2,182 
Total Adjusted Segment EBITDA$150,091 $112,746